1. Home
  2. ORIC vs SPTN Comparison

ORIC vs SPTN Comparison

Compare ORIC & SPTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORIC
  • SPTN
  • Stock Information
  • Founded
  • ORIC 2014
  • SPTN 1917
  • Country
  • ORIC United States
  • SPTN United States
  • Employees
  • ORIC N/A
  • SPTN N/A
  • Industry
  • ORIC Biotechnology: Pharmaceutical Preparations
  • SPTN Food Distributors
  • Sector
  • ORIC Health Care
  • SPTN Consumer Discretionary
  • Exchange
  • ORIC Nasdaq
  • SPTN Nasdaq
  • Market Cap
  • ORIC 362.9M
  • SPTN 596.4M
  • IPO Year
  • ORIC 2020
  • SPTN N/A
  • Fundamental
  • Price
  • ORIC $10.85
  • SPTN $26.57
  • Analyst Decision
  • ORIC Strong Buy
  • SPTN Hold
  • Analyst Count
  • ORIC 9
  • SPTN 1
  • Target Price
  • ORIC $18.29
  • SPTN $26.90
  • AVG Volume (30 Days)
  • ORIC 932.0K
  • SPTN 1.4M
  • Earning Date
  • ORIC 08-11-2025
  • SPTN 08-14-2025
  • Dividend Yield
  • ORIC N/A
  • SPTN 3.28%
  • EPS Growth
  • ORIC N/A
  • SPTN N/A
  • EPS
  • ORIC N/A
  • SPTN N/A
  • Revenue
  • ORIC N/A
  • SPTN $9,652,685,000.00
  • Revenue This Year
  • ORIC N/A
  • SPTN $6.00
  • Revenue Next Year
  • ORIC N/A
  • SPTN N/A
  • P/E Ratio
  • ORIC N/A
  • SPTN N/A
  • Revenue Growth
  • ORIC N/A
  • SPTN 0.26
  • 52 Week Low
  • ORIC $3.90
  • SPTN $17.30
  • 52 Week High
  • ORIC $14.67
  • SPTN $26.69
  • Technical
  • Relative Strength Index (RSI)
  • ORIC 61.82
  • SPTN 77.24
  • Support Level
  • ORIC $10.72
  • SPTN $26.37
  • Resistance Level
  • ORIC $11.45
  • SPTN $26.69
  • Average True Range (ATR)
  • ORIC 0.58
  • SPTN 0.10
  • MACD
  • ORIC -0.08
  • SPTN -0.07
  • Stochastic Oscillator
  • ORIC 57.65
  • SPTN 57.81

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

About SPTN SpartanNash Company

SpartanNash Co is a food solutions company that delivers the ingredients. Its principal business activities include, distributing grocery products to a diverse group of independent and chain retailers, its corporate-owned retail stores, and U.S. military commissaries and exchanges; as well as operating a fresh produce distribution network and the Our Family private label brand. The company operates in two segments: Retail and Wholesale. Majority of the revenue is earned from its Wholesale segment which uses a multi-channel sales approach to distribute national brand and private brand products to independent retailers, national accounts, food service distributors, e-commerce providers, and the Company's corporate owned retail stores.

Share on Social Networks: